Programmed Death Ligand 1 (PD-L1) Expression in Primary Angiosarcoma

Journal of Cancer - Australia
doi 10.7150/jca.19060
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Ivyspring International Publisher

Related search

Clinicopathologic Significance and Immunogenomic Analysis of Programmed Death-Ligand 1 (PD-L1) and Programmed Death 1 (PD-1) Expression in Thymic Epithelial Tumors

Frontiers in Oncology
Cancer ResearchOncology
2019English

Comprehensive Immunohistochemical Study of Programmed Cell Death Ligand 1 (PD-L1)

American Journal of Surgical Pathology
AnatomyForensic MedicinePathologySurgery
2016English

A Network of Endogenous Metabolites Modulates Programmed Death-Ligand 1 (PD-L1) Expression in Monocytic Leukemia

Biophysical Journal
Biophysics
2019English

PD-1 Receptor (PDCD1; PD-1; CD279); Programmed Cell Death 1 Ligand 1 (CD274 Molecule; PD-L1; B7-H1)

Science-Business eXchange
2010English

Sarcomatoid Lung Carcinomas Show High Levels of Programmed Death Ligand-1 (PD-L1)

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2013English

Programmed Cell Death Ligand 1 (PD-L1) Signaling Regulates Macrophage Proliferation and Activation

Cancer immunology research
Cancer ResearchImmunology
2018English

Cisplatin Contributes to Programmed Death-Ligand 1 (PD-L1) Expression in Bladder Cancer Through ERK1/2 - AP-1 Signaling Pathway

Bioscience Reports
BiochemistryCell BiologyMolecular BiologyBiophysics
2019English

P2.04-01 Associations Histological Subtype of Lung Adenocarcinoma and Programmed Death Ligand 1 (PD-L1) Expression in Tumor Cells.

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Poor Outcome With Anti-Programmed Death-Ligand 1 (PD-L1) Antibody Due to Poor Pharmacokinetic Properties in PD-1/PD-L1 Blockade-Sensitive Mouse Models

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy